Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

BRIEF-CropLogic Says Atlas Capital Markets To Provide Up To A$20 Mln Of Funding

Published 20/12/2019, 11:29 pm

Dec 20 (Reuters) - CropLogic Ltd CLI.AX :

* ATLAS CAPITAL MARKETS AGREED TO STRATEGIC SHARE PLACEMENT FACILITY TO PROVIDE UP TO A$20 MILLION OF FUNDING IN NEXT 12-36 MONTHS

* HEMP TRIAL FARM OPERATED BY UNIT WAS AFFECTED LATE SEASON BY AN ADVERSE WEATHER EVENT

* CROPLOGIC LTD PROPOSES TO EXPLORE A CENTRALISED CORPORATE FARMER OPTION FOR BUYERS OF CBD HEMP

* SHIPMENTS TO DESCHUTES LABS HAVE BEEN SUSPENDED

* DUE TO IMPACT OF ADVERSE WEATHER, BIOMASS FROM HEMP TRIAL FARM WILL NOT MEET MINIMUM REQUIREMENT OF 8% CBD FOR DESCHUTES LABS DEAL

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.